Video, page-25

First 25 Last

Share
Profile

Follow
asxunsullied

1,619 Posts.

189

02/08/24

10:39

Post #: 75041004
Share

Originally posted by djkencloud: ↑

My issue with the stock at present (and why I have sold down to a small amount) is that if the trial/FDA approval takes another two/three years, they might need to raise nearly as much money as the current market cap over that period.

That will put constant downward pressure on the SP while diluting my shares by 50%. And despite their incredible product, why invest now when I can invest down the line when they've finished raising significant sums of money every three months?

I had been hoping for a takeover by Edwards or other, but I'm sure there is some sense in those companies just standing back and letting AVR play out over the next few years and seeing where the share price ends up.

As much as Wayne has experience in big pharma and large trials (which is great), I sometimes wonder if he thinks there are any limits to pre-revenue companies, as we've had more staff each quarter for the last three years.

In saying all that, the product is so good I expect it to get there in the end somehow.

Good luck all.

Expand

Absolutely spot on analysis. Well done for understanding what it's like to be a small shareholder in the real Anteris
NA/IMO

Last edited by asxunsullied: 02/08/24

AVR Price at posting: $15.05 Sentiment: None Disclosure: Not Held
1 Upvote

0 Great analysis

Reply

Top Stories

LTR

Liontown locks in $266M placement to help cashflow, Kathleen Valley ramp-up

Oz will likely unveil commodity price supports, but don't expect Trumpian flare

Thursday's HotCopper trends: $266M LTR placement, Trigg expansion | Aug 7

ETM

As Trump-Greenland hype dies off, Energy Transition buys a niobium project in Spain

MQR

'We're extremely encouraged': Marquee expands footprint at Mt Clement

First 25 Last

Add to My Watchlist

What is My Watchlist?

A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

(20min delay)
Last $5.68		Change 0.180(3.27%)		Mkt cap ! $87.92M

Open	High	Low	Value	Volume
$5.29	$5.70	$5.29	$141.5K	25.44K

Buyers (Bids)

No.	Vol.	Price($)
3	1272	$5.50

Sellers (Offers)

Price($)	Vol.	No.
$5.70	367	1

View Market Depth

No.	Vol.	Price($)
3	1272	5.500
2	6497	5.260
1	8000	5.250
1	9500	5.240
1	2000	5.230

Price($)	Vol.	No.
5.700	367	1
5.750	30	1
5.760	20000	1
5.900	500	1
5.920	11	1

Last trade - 13.22pm 07/08/2025 (20 minute delay)

AVR (ASX) Chart

Video, page-25

Liontown locks in $266M placement to help cashflow, Kathleen Valley ramp-up

Oz will likely unveil commodity price supports, but don't expect Trumpian flare

Thursday's HotCopper trends: $266M LTR placement, Trigg expansion | Aug 7

As Trump-Greenland hype dies off, Energy Transition buys a niobium project in Spain

'We're extremely encouraged': Marquee expands footprint at Mt Clement

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News

Video, page-25

Top Stories

Liontown locks in $266M placement to help cashflow, Kathleen Valley ramp-up

Oz will likely unveil commodity price supports, but don't expect Trumpian flare

Thursday's HotCopper trends: $266M LTR placement, Trigg expansion | Aug 7

As Trump-Greenland hype dies off, Energy Transition buys a niobium project in Spain

'We're extremely encouraged': Marquee expands footprint at Mt Clement

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News